Long-term low-dose exposure of human urothelial cells to sodium arsenite activates lipocalin-2 via promoter hypomethylation

Hsiu Hua Wang, Meei Maan Wu, Michael W Y Chan, Yeong Shiau Pu, Chien Jen Chen, Te Chang Lee

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

We previously reported that the sustained exposure of human urothelial cells (HUCs) to low-dose sodium arsenite induces changes in the gene expression profile and neoplastic transformation. In this study, we used the HumanMethylation27 BeadChip to analyze genome-wide methylation profiles and 5-aza-2′-deoxycytidine to examine the involvement of promoter methylation in gene expression. Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-κB and C/EBP-α significantly reduced LCN2 promoter activity. By chromatin immunoprecipitation assay, we demonstrated the significantly increased binding of RelA (p65) and NF-κB1 (p50) to the hypomethylated promoter of LCN2 in the iAs-HUCs. Furthermore, we also demonstrated that LCN2 overexpression was crucial for the neoplastic characteristics of the iAs-HUCs, such as enhanced anchorage-independent growth, resistance to serum deprivation and activation of NF-κB signaling. In addition, our results indicated that enhanced NF-κB activity in iAs-HUCs was via LCN2-mediated increase in intracellular iron and reactive oxygen species levels. Taken together, our results show that sustained low-dose arsenic exposure results in epigenetic changes and enhanced oncogenic potential via LCN2 overexpression.

Original languageEnglish
Pages (from-to)1549-1559
Number of pages11
JournalArchives of Toxicology
Volume88
Issue number8
DOIs
Publication statusPublished - 2014

Fingerprint

Lipocalins
Arsenic
Methylation
decitabine
Gene expression
Chromatin Immunoprecipitation
Transcriptome
Urinary Bladder Neoplasms
Epigenomics
Chromatin
sodium arsenite
Lipocalin-2
Assays
Reactive Oxygen Species
Iron
Genes
Chemical activation
Genome
Tissue
Gene Expression

Keywords

  • Bladder cancer
  • DNA methylation
  • Epigenetic alterations
  • Inorganic arsenic
  • Lipocalin-2
  • Urothelial cells

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Long-term low-dose exposure of human urothelial cells to sodium arsenite activates lipocalin-2 via promoter hypomethylation. / Wang, Hsiu Hua; Wu, Meei Maan; Chan, Michael W Y; Pu, Yeong Shiau; Chen, Chien Jen; Lee, Te Chang.

In: Archives of Toxicology, Vol. 88, No. 8, 2014, p. 1549-1559.

Research output: Contribution to journalArticle

Wang, Hsiu Hua ; Wu, Meei Maan ; Chan, Michael W Y ; Pu, Yeong Shiau ; Chen, Chien Jen ; Lee, Te Chang. / Long-term low-dose exposure of human urothelial cells to sodium arsenite activates lipocalin-2 via promoter hypomethylation. In: Archives of Toxicology. 2014 ; Vol. 88, No. 8. pp. 1549-1559.
@article{881085040c3c4edcb4844163759b035a,
title = "Long-term low-dose exposure of human urothelial cells to sodium arsenite activates lipocalin-2 via promoter hypomethylation",
abstract = "We previously reported that the sustained exposure of human urothelial cells (HUCs) to low-dose sodium arsenite induces changes in the gene expression profile and neoplastic transformation. In this study, we used the HumanMethylation27 BeadChip to analyze genome-wide methylation profiles and 5-aza-2′-deoxycytidine to examine the involvement of promoter methylation in gene expression. Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-κB and C/EBP-α significantly reduced LCN2 promoter activity. By chromatin immunoprecipitation assay, we demonstrated the significantly increased binding of RelA (p65) and NF-κB1 (p50) to the hypomethylated promoter of LCN2 in the iAs-HUCs. Furthermore, we also demonstrated that LCN2 overexpression was crucial for the neoplastic characteristics of the iAs-HUCs, such as enhanced anchorage-independent growth, resistance to serum deprivation and activation of NF-κB signaling. In addition, our results indicated that enhanced NF-κB activity in iAs-HUCs was via LCN2-mediated increase in intracellular iron and reactive oxygen species levels. Taken together, our results show that sustained low-dose arsenic exposure results in epigenetic changes and enhanced oncogenic potential via LCN2 overexpression.",
keywords = "Bladder cancer, DNA methylation, Epigenetic alterations, Inorganic arsenic, Lipocalin-2, Urothelial cells",
author = "Wang, {Hsiu Hua} and Wu, {Meei Maan} and Chan, {Michael W Y} and Pu, {Yeong Shiau} and Chen, {Chien Jen} and Lee, {Te Chang}",
year = "2014",
doi = "10.1007/s00204-014-1214-x",
language = "English",
volume = "88",
pages = "1549--1559",
journal = "Archiv fur Toxikologie",
issn = "0003-9446",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Long-term low-dose exposure of human urothelial cells to sodium arsenite activates lipocalin-2 via promoter hypomethylation

AU - Wang, Hsiu Hua

AU - Wu, Meei Maan

AU - Chan, Michael W Y

AU - Pu, Yeong Shiau

AU - Chen, Chien Jen

AU - Lee, Te Chang

PY - 2014

Y1 - 2014

N2 - We previously reported that the sustained exposure of human urothelial cells (HUCs) to low-dose sodium arsenite induces changes in the gene expression profile and neoplastic transformation. In this study, we used the HumanMethylation27 BeadChip to analyze genome-wide methylation profiles and 5-aza-2′-deoxycytidine to examine the involvement of promoter methylation in gene expression. Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-κB and C/EBP-α significantly reduced LCN2 promoter activity. By chromatin immunoprecipitation assay, we demonstrated the significantly increased binding of RelA (p65) and NF-κB1 (p50) to the hypomethylated promoter of LCN2 in the iAs-HUCs. Furthermore, we also demonstrated that LCN2 overexpression was crucial for the neoplastic characteristics of the iAs-HUCs, such as enhanced anchorage-independent growth, resistance to serum deprivation and activation of NF-κB signaling. In addition, our results indicated that enhanced NF-κB activity in iAs-HUCs was via LCN2-mediated increase in intracellular iron and reactive oxygen species levels. Taken together, our results show that sustained low-dose arsenic exposure results in epigenetic changes and enhanced oncogenic potential via LCN2 overexpression.

AB - We previously reported that the sustained exposure of human urothelial cells (HUCs) to low-dose sodium arsenite induces changes in the gene expression profile and neoplastic transformation. In this study, we used the HumanMethylation27 BeadChip to analyze genome-wide methylation profiles and 5-aza-2′-deoxycytidine to examine the involvement of promoter methylation in gene expression. Because the expression of lipocalin-2 (LCN2) was highly enhanced by promoter hypomethylation in inorganic arsenic (iAs)-HUCs cells as well as bladder cancer tissues, we further showed that mutations at the binding sequences for NF-κB and C/EBP-α significantly reduced LCN2 promoter activity. By chromatin immunoprecipitation assay, we demonstrated the significantly increased binding of RelA (p65) and NF-κB1 (p50) to the hypomethylated promoter of LCN2 in the iAs-HUCs. Furthermore, we also demonstrated that LCN2 overexpression was crucial for the neoplastic characteristics of the iAs-HUCs, such as enhanced anchorage-independent growth, resistance to serum deprivation and activation of NF-κB signaling. In addition, our results indicated that enhanced NF-κB activity in iAs-HUCs was via LCN2-mediated increase in intracellular iron and reactive oxygen species levels. Taken together, our results show that sustained low-dose arsenic exposure results in epigenetic changes and enhanced oncogenic potential via LCN2 overexpression.

KW - Bladder cancer

KW - DNA methylation

KW - Epigenetic alterations

KW - Inorganic arsenic

KW - Lipocalin-2

KW - Urothelial cells

UR - http://www.scopus.com/inward/record.url?scp=84904979200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904979200&partnerID=8YFLogxK

U2 - 10.1007/s00204-014-1214-x

DO - 10.1007/s00204-014-1214-x

M3 - Article

VL - 88

SP - 1549

EP - 1559

JO - Archiv fur Toxikologie

JF - Archiv fur Toxikologie

SN - 0003-9446

IS - 8

ER -